EPISODE · Jan 20, 2022 · 12 MIN
MPR Weekly Dose 104 - Two New Atopic Dermatitis Therapies; Counterfeit HIV; Indications Withdrawn for Zydelig; CDC Pediatric Influenza Vaccine Study Results; COVID Test Warning
from MPR Weekly Dose
This week we have news of two new approval for atopic dermatitis; Warnings around counterfeit HIV treatments; Zydelig indications withdrawn; CDC pediatric influenza vaccine study results; And an FDA warning against a particular brand of COVID-19 antibody tests.
Embed this episode
Ready to play
MPR Weekly Dose 104 - Two New Atopic Dermatitis Therapies; Counterfeit HIV; Indications Withdrawn for Zydelig; CDC Pediatric Influenza Vaccine Study Results; COVID Test Warning
0:00
12:33
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of MPR Weekly Dose?
This episode is 12 minutes long.
When was this MPR Weekly Dose episode published?
This episode was published on January 20, 2022.
Can I download this MPR Weekly Dose episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!